Form 4: Axogen CFO's Equity Holdings Update

Axogen CFO Lindsey Hartley reported the vesting of 9,000 restricted stock units and subsequent tax-related share withholdings.

Summary

• Axogen, Inc. CFO Lindsey Hartley reported transactions involving common stock and restricted stock units (RSUs).
• On March 16, 2026, 4,000 RSUs vested, resulting in the acquisition of 4,000 shares of common stock at a price of $0.
• Concurrently, 1,574 shares were disposed of at $32.84 per share to satisfy tax withholding obligations related to the RSU vesting.
• Additionally, 5,000 RSUs fully vested on March 16, 2026, leading to the acquisition of 5,000 shares of common stock at a price of $0.
• Another 1,968 shares were disposed of at $32.84 per share for tax withholding purposes related to this second RSU vesting.
• Following these transactions, Ms. Hartley's direct beneficial ownership of Axogen common stock stands at 60,734 shares.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive event, reflecting routine executive compensation and continued alignment of management's interests with shareholders, without indicating any new strategic or operational developments.

Positives

• The vesting of 9,000 restricted stock units indicates continued long-term incentive alignment between the CFO and shareholder interests.
• The increase in direct beneficial ownership of common stock, even after tax withholding, demonstrates management's ongoing equity stake in the company.

Negatives

• A total of 3,542 shares (1,574 + 1,968) were disposed of to cover tax obligations, reducing the net shares received from vesting.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that RSU vesting and subsequent tax withholding are standard practices for executive compensation in the biotechnology and medical device industry, reflecting a common mechanism for aligning executive incentives with long-term company performance.

Comparison to Industry Standards

• Executive equity compensation, particularly through restricted stock units, is a prevalent practice across publicly traded companies, including peers in the medical technology sector such as Stryker (SYK) or Medtronic (MDT).
• The reported transactions align with typical executive compensation structures designed to incentivize long-term value creation, where a portion of vested shares is commonly sold to cover tax liabilities.

Stakeholder Impact

• Shareholders: The transactions demonstrate continued executive alignment with shareholder interests through equity ownership.
• Employees: Reflects standard executive compensation practices, which can influence broader employee incentive programs.

Key Dates

Recommendation

This Form 4 filing details routine executive compensation events (RSU vesting and tax-related share sales) and does not provide new material information regarding the company's operational performance, strategic direction, or financial health that would warrant a change in investment recommendation. It primarily confirms the CFO's ongoing equity stake.

Keywords

Axogen, AXGN, Lindsey Hartley, CFO, SEC Form 4, Restricted Stock Units, RSU vesting, Insider Trading, Equity Compensation, Stock Ownership